Neuren Pharmaceuticals Limited (AU:NEU) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuren Pharmaceuticals Limited has disclosed a change in the interest of their Director, Joseph Basile, who has increased his stake in the company. On June 11, 2024, Basile purchased an additional 5,000 ordinary shares via an on-market trade for a total consideration of $97,450, or $19.49 per share, raising his total holdings to 15,000 shares. This financial activity was reported in compliance with ASX listing rule 3.19A.2.
For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.